These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6478056

  • 1. Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors.
    Jackson MJ, Jones DA, Harris EJ.
    Biosci Rep; 1984 Jul; 4(7):581-7. PubMed ID: 6478056
    [Abstract] [Full Text] [Related]

  • 2. Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolated rat hepatocytes.
    Stacey NH, Klaassen CD.
    J Toxicol Environ Health; 1982 Mar; 9(3):439-50. PubMed ID: 6284950
    [Abstract] [Full Text] [Related]

  • 3. Effects of local anaesthetics on phospholipases.
    Kunze H, Nahas N, Traynor JR, Wurl M.
    Biochim Biophys Acta; 1976 Jul 20; 441(1):93-102. PubMed ID: 952985
    [Abstract] [Full Text] [Related]

  • 4. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
    Filippov A, Skatova G, Porotikov V, Kobrinsky E, Saxon M.
    Gen Physiol Biophys; 1989 Apr 20; 8(2):113-8. PubMed ID: 2777057
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of agonist-induced degradation of muscarinic cholinergic receptor by quinacrine and tetracaine--possible involvement of phospholipase A2 in receptor degradation.
    Higuchi H, Uchida S, Matsumoto K, Yoshida H.
    Eur J Pharmacol; 1983 Oct 28; 94(3-4):229-39. PubMed ID: 6653661
    [Abstract] [Full Text] [Related]

  • 6. The effects of non-steroidal inhibitors of phospholipase A2 on leukotriene and histamine release from human and guinea-pig lung.
    Kench JG, Seale JP, Temple DM, Tennant C.
    Prostaglandins; 1985 Aug 28; 30(2):199-208. PubMed ID: 2413502
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
    Tanaka N, Kagawa S, Murakoso K, Shimizu S, Matsuoka A.
    Horm Metab Res; 1983 May 28; 15(5):255-6. PubMed ID: 6409772
    [No Abstract] [Full Text] [Related]

  • 8. The role of phospholipase A2 in calcium-induced damage in cardiac and skeletal muscle.
    Duncan CJ.
    Cell Tissue Res; 1988 Aug 28; 253(2):457-62. PubMed ID: 3136926
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T, Yamamoto S, Ishii M, Kato R.
    Cancer Res; 1982 Jul 28; 42(7):2841-5. PubMed ID: 6805948
    [Abstract] [Full Text] [Related]

  • 10. The role of phospholipase A activity in rat liver microsomal lipid peroxidation.
    Beckman JK, Borowitz SM, Burr IM.
    J Biol Chem; 1987 Feb 05; 262(4):1479-84. PubMed ID: 3805035
    [Abstract] [Full Text] [Related]

  • 11. Phospholipase A2 inhibitors. Differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide.
    Erman A, Azuri R, Raz A.
    Biochem Pharmacol; 1983 Jul 01; 32(13):2083-7. PubMed ID: 6870935
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of enzymic and non-enzymic lipid peroxidation of flounder muscle sarcoplasmic reticulum by pretreatment with phospholipase A2.
    Shewfelt RL, Hultin HO.
    Biochim Biophys Acta; 1983 May 16; 751(3):432-8. PubMed ID: 6849952
    [Abstract] [Full Text] [Related]

  • 13. The role of phospholipase A2 in microsomal lipid peroxidation induced with t-butyl hydroperoxide.
    Borowitz SM, Montgomery C.
    Biochem Biophys Res Commun; 1989 Feb 15; 158(3):1021-8. PubMed ID: 2920033
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E, Gougat J, Navarro J, Delahayes JF.
    J Pharm Pharmacol; 1979 Sep 15; 31(9):588-92. PubMed ID: 41058
    [Abstract] [Full Text] [Related]

  • 15. The influence of phospholipase A2 and glutathione peroxidase on the elimination of membrane lipid peroxides.
    Sevanian A, Muakkassah-Kelly SF, Montestruque S.
    Arch Biochem Biophys; 1983 Jun 15; 223(2):441-52. PubMed ID: 6859870
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrine.
    Authi KS, Traynor JR.
    J Pharm Pharmacol; 1982 Nov 15; 34(11):736-8. PubMed ID: 6129307
    [No Abstract] [Full Text] [Related]

  • 17. [Inhibition of phospholipid hydrolysis by phospholipase A2 in microsomal and mitochondrial membranes subjected to lipid peroxidation].
    Balevska PS, Kassabova EM, Rusanov EM, Kagan VE.
    Biull Eksp Biol Med; 1985 Feb 15; 99(2):161-4. PubMed ID: 3971034
    [Abstract] [Full Text] [Related]

  • 18. Dantrolene and mepacrine antagonize the hemolysis of human red blood cells by halothane and bee venom phospholipase A2.
    Fletcher JE, Kistler P, Rosenberg H, Michaux K.
    Toxicol Appl Pharmacol; 1987 Sep 30; 90(3):410-9. PubMed ID: 3660410
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of dog kidney Na+, K+-ATPase activity by procaine, tetracaine and dibucaine.
    Hudgins PM, Bond GH.
    Biochem Pharmacol; 1984 Jun 01; 33(11):1789-96. PubMed ID: 6145421
    [Abstract] [Full Text] [Related]

  • 20. Local anesthetic inhibition of pancreatic phospholipase A2 action on lecithin monolayers.
    Hendrickson HS, van Dam-Mieras MC.
    J Lipid Res; 1976 Jul 01; 17(4):399-405. PubMed ID: 133195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.